PER percheron therapeutics limited

ATL1102 US Patent - very interesting, page-31

  1. 979 Posts.
    lightbulb Created with Sketch. 361
    Agree Itsa, ANP is the dark horse that has bolted to the lead.. one trial away from commercialisation and a $100M voucher waiting to fast track the drug to market. Big Pharma knows all too well that Gene Therapy is failing on its own and I believe there is a bidding war going on behind closed doors to see who will partner this micro cap into the big league. Billions of dollars at stake and numerous indications that require a solution for inflammation. Once we have approval for the Ph2b trial the SP will rally like we have never seen before.. so excited for the next few months.. insto's still busily accumulating and manipulating the SP.. DONT SELL!!! this rocket is about to take off..
    Last edited by monti901: 14/03/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.001(12.5%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $2.2K 250K

Buyers (Bids)

No. Vol. Price($)
23 6305225 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 2230150 7
View Market Depth
Last trade - 12.01pm 10/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.